检索结果 - Ian Glaspole

Refine Results
  1. 1
    Steroid therapy in acute exacerbation of fibrotic interstitial lung disease

    Steroid therapy in acute exacerbation of fibrotic interstitial lung disease 由 Kavya Koshy, Hayley Barnes, Erica Farrand, Ian Glaspole

    出版 2024
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Cyclophosphamide for connective tissue disease-associated interstitial lung disease

    Cyclophosphamide for connective tissue disease-associated interstitial lung disease 由 Hayley Barnes, Anne E. Holland, Glen P. Westall, Nicole Goh, Ian Glaspole

    出版 2018
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  3. 3
    Predictors of benefit following pulmonary rehabilitation for interstitial lung disease

    Predictors of benefit following pulmonary rehabilitation for interstitial lung disease 由 Anne E. Holland, Catherine J. Hill, Ian Glaspole, Nicole Goh, Christine F. McDonald

    出版 2011
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Prevalence and prognosis of unclassifiable interstitial lung disease

    Prevalence and prognosis of unclassifiable interstitial lung disease 由 Lauren Troy, Ian Glaspole, Nicole Goh, Christopher Zappala, Peter Hopkins, Margaret Wilsher, Yuben Moodley, Tamera J. Corte

    出版 2014
    获取全文 获取全文
    Carta
    加到收藏夹
    Saved in:
  5. 5
    Oxygen therapy for interstitial lung disease: a systematic review

    Oxygen therapy for interstitial lung disease: a systematic review 由 Emily C. Bell, Narelle S. Cox, Nicole Goh, Ian Glaspole, Glen P. Westall, Alice Watson, Anne E. Holland

    出版 2017
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  6. 6
    Be honest and help me prepare for the future

    Be honest and help me prepare for the future 由 Anne E. Holland, Julio F. Fiore, Nicole Goh, Karen Symons, Leona Dowman, Glen P. Westall, Anita Hazard, Ian Glaspole

    出版 2015
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Dyspnoea and comorbidity contribute to anxiety and depression in interstitial lung disease

    Dyspnoea and comorbidity contribute to anxiety and depression in interstitial lung disease 由 Anne E. Holland, Julio F. Fiore, Emily C. Bell, Nicole Goh, Glen P. Westall, Karen Symons, Leona Dowman, Ian Glaspole

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Evaluating the interstitial lung disease multidisciplinary meeting: a survey of expert centres

    Evaluating the interstitial lung disease multidisciplinary meeting: a survey of expert centres 由 Helen E. Jo, Tamera J. Corte, Yuben Moodley, Kovi Levin, Glen P. Westall, Peter Hopkins, Daniel C. Chambers, Ian Glaspole

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Health-related quality of life of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis

    Health-related quality of life of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis 由 Ingrid A. Cox, Nicolás Borchers Arriagada, Barbara de Graaff, Tamera J. Corte, Ian Glaspole, Stella T. Lartey, E. Haydn Walters, Andrew Palmer

    出版 2020
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  10. 10
    The interstitial lung disease multidisciplinary meeting: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia

    The interstitial lung disease multidisciplinary meeting: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia 由 Jyotika D. Prasad, Annabelle Mahar, Jane Bleasel, Samantha Ellis, Daniel C. Chambers, Fiona Lake, Peter Hopkins, Tamera J. Corte, Heather Allan, Ian Glaspole

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    P174 Effect of continued treatment with pirfenidone following a ≥10% relative decline in percent predicted forced vital capacity (%FVC) in patients with idiopathic pulmonary fibrosis (IPF)

    P174 Effect of continued treatment with pirfenidone following a ≥10% relative decline in percent predicted forced vital capacity (%FVC) in patients with idiopathic pulmonary fibros... 由 AU Wells, Carlo Albera, Ulrich Costabel, Ian Glaspole, MK Glassberg, Lisa Lancaster, DJ Lederer, CA Pereira, JJ Swigris, B-M Day, Will Chou, S.D. Nathan

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    S109 Effect of continued treatment with pirfenidone following a clinically meaningful decline in percent predicted forced vital capacity in patients with idiopathic pulmonary fibrosis (IPF): Abstract S109 Table 1

    S109 Effect of continued treatment with pirfenidone following a clinically meaningful decline in percent predicted forced vital capacity in patients with idiopathic pulmonary fibro... 由 PW Noble, Carlo Albera, WZ Bradford, Ulrich Costabel, Ian Glaspole, MK Glassberg, Lisa Lancaster, DJ Lederer, Lin Zhu, CA Pereira, JJ Swigris, Dominique Valeyre, S.D. Nathan

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    P13 Safety of pirfenidone in patients with idiopathic pulmonary fibrosis (IPF): Integrated analysis of cumulative data from 5 clinical trials: Abstract P13 Table 1

    P13 Safety of pirfenidone in patients with idiopathic pulmonary fibrosis (IPF): Integrated analysis of cumulative data from 5 clinical trials: Abstract P13 Table 1 由 PW Noble, Carlo Albera, WZ Bradford, Ulrich Costabel, Ian Glaspole, MK Glassberg, DJ Lederer, Lin Zhu, S.D. Nathan, CA Pereira, JJ Swigris, Dominique Valeyre, Lisa Lancaster

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    S97 Annual rate of fvc decline in various patient sub-groups with idiopathic pulmonary fibrosis treated with pirfenidone: pooled analysis from 3 pivotal studies

    S97 Annual rate of fvc decline in various patient sub-groups with idiopathic pulmonary fibrosis treated with pirfenidone: pooled analysis from 3 pivotal studies 由 PW Noble, Carlo Albera, Will Chou, Ulrich Costabel, B. L. Day, Ian Glaspole, MK Glassberg, Lisa Lancaster, DJ Lederer, S.D. Nathan, CA Pereira, John L. Stauffer, JJ Swigris

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Efficacy of Pirfenidone in the Context of Multiple Disease Progression Events in Patients With Idiopathic Pulmonary Fibrosis

    Efficacy of Pirfenidone in the Context of Multiple Disease Progression Events in Patients With Idiopathic Pulmonary Fibrosis 由 Steven D. Nathan, Ulrich Costabel, Ian Glaspole, Marilyn K. Glassberg, Lisa Lancaster, David J. Lederer, Carlos A.C. Pereira, Benjamin Trzaskoma, Elizabeth Morgenthien, Susan L. Limb, Athol U. Wells

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Health‐related quality of life in idiopathic pulmonary fibrosis: Data from the <scp>A</scp>ustralian <scp>IPF R</scp>egistry

    Health‐related quality of life in idiopathic pulmonary fibrosis: Data from the <scp>A</scp>ustralian <scp>IPF R</scp>egistry 由 Ian Glaspole, Sally Chapman, Wendy A. Cooper, Samantha Ellis, Nicole Goh, Peter Hopkins, Sacha Macansh, Annabelle Mahar, Yuben Moodley, Eldho Paul, Paul N. Reynolds, E. Haydn Walters, Christopher Zappala, Tamera J. Corte

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial

    The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial 由 Leona Dowman, Christine F. McDonald, Catherine J. Hill, Annemarie L. Lee, Kathryn Barker, Claire Boote, Ian Glaspole, Nicole Goh, Anne Marie Southcott, Angela T. Burge, Rebecca Gillies, Alicia Martin, Anne E. Holland

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    Machine learning in radiology: the new frontier in interstitial lung diseases

    Machine learning in radiology: the new frontier in interstitial lung diseases 由 Hayley Barnes, Stephen M. Humphries, Peter M. George, Deborah Assayag, Ian Glaspole, John A. Mackintosh, Tamera J. Corte, Marilyn K. Glassberg, Kerri A. Johannson, Lucio Calandriello, Federico Felder, Athol U. Wells, Simon Walsh

    出版 2022
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  19. 19
    P14 Pirfenidone is efficacious in patients with idiopathic pulmonary fibrosis (IPF) with more preserved lung function

    P14 Pirfenidone is efficacious in patients with idiopathic pulmonary fibrosis (IPF) with more preserved lung function 由 PW Noble, WZ Bradford, Ulrich Costabel, Ian Glaspole, MK Glassberg, Eduard Gorina, David Kardatzke, Lisa Lancaster, DJ Lederer, S.D. Nathan, Carlos Alberto de Castro Pereira, Dominique Spirig, JJ Swigris, Dominique Valeyre, Carlo Albera

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    A Composite Serum Biomarker Index for the Diagnosis of Systemic Sclerosis–Associated Interstitial Lung Disease: A Multicenter, Observational Cohort Study

    A Composite Serum Biomarker Index for the Diagnosis of Systemic Sclerosis–Associated Interstitial Lung Disease: A Multicenter, Observational Cohort Study 由 Adelle S. Jee, Iain Stewart, Peter Youssef, Stephen Adelstein, Donna Lai, Sheng Hua, Wendy Stevens, Susanna Proudman, Gene‐Siew Ngian, Ian Glaspole, Yuben Moodley, Jane Bleasel, Sacha Macansh, Mandana Nikpour, Joanne Sahhar, Tamera J. Corte

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: